Back

Implication on how to best identify and treat HF patients with tricuspid regurgitation

30 August 2024 (12:35 - 12:50)
Organised by: Logo
Congress Presentation Part of: Hot or not debate - transcatheter tricuspid interventions now and tomorrow Valvular Heart Disease Open Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Ali Vazir

Royal Brompton Hospital, London (United Kingdom of Great Britain & Northern Ireland)

6 More presentations in this session

Presentation thumbnail
Introduction
Professor S. Windecker (Bern, CH) Professor M. Boehm (Homburg, DE)
Video
Presentation thumbnail
Con - transcatheter tricuspid valve therapies are NOT hot and will remain only a niche
Associate Professor M. Adamo (Brescia, IT)
Slides Video
Presentation thumbnail
Pro - transcatheter tricuspid valve therapies are HOT and are a foundation therapy for patients with HF and tricuspid regurgitation
Professor P. Lurz (Mainz, DE)
Slides Video
Presentation thumbnail
Conclusion
Associate Professor M. Adamo (Brescia, IT) Professor P. Lurz (Mainz, DE)
Video
Presentation thumbnail
Update and current status on transcatheter therapies for tricuspid regurgitation
Doctor S. Zieroth (Winnipeg, CA)
Slides Video

Access the full session

Session thumbnail
Hot or not debate - transcatheter tricuspid interventions now and tomorrow
Video

The Event

Event poster

ESC Congress 2024

30 August 2024 12:35 CET
You may be interested in
thumbnail
Congress Presentation
Clinical evaluation and optimal medical management of tricuspid regurgitation
thumbnail
Congress Session
Tricuspid regurgitation: problems and solutions
thumbnail
Congress Presentation
Tricuspid regurgitation and heart failure: focus on the optimal indication for intervention

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources